Opsens Inc. (OPSSF)
Chart Events
Performance Outlook
| Previous Close | 2.0150 |
| Open | 1.9900 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 1.9900 - 1.9900 |
| 52 Week Range | 1.2000 - 2.9900 |
| Volume | |
| Avg. Volume | 23,448 |
| Market Cap | 216.564M |
| Beta (5Y Monthly) | 0.62 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0460 |
| Earnings Date | Jul 14, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for OPSSF
Related Research
- OPSENS INCDaily – Vickers Top Buyers & Sellers for 05/09/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.RatingFair ValueEconomic Moat3 months agoArgus Research
- CNW Group
OPSENS ANNOUNCES THIRD QUARTER FISCAL 2022 FINANCIAL RESULTS WITH RECORD QUARTERLY REVENUES
OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, today released results for its third quarter ended May 31, 2022.
- CNW Group
OpSens Awarded Interventional Specialty Diagnostics Agreement with Premier for OptoWire III
OpSens Inc.. ("OpSens" or the "Company") (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology has been awarded a national group purchasing agreement for Interventional Specialty Diagnostics with Premier, Inc. (Premier), a leading healthcare improvement company uniting an alliance with approximately 4,400 U.S. hospitals and health systems. Effective July 1st, the new agreement allows Premier members, at th
- CNW Group
OPSENS TO HOST THIRD QUARTER FISCAL YEAR 2022 FINANCIAL RESULTS CONFERENCE CALL ON THURSDAY, JULY 14
OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, will report financial results for its third quarter of fiscal year 2022, ended May 31st, on Thursday, July 14, before the open of the market. The Company has scheduled a conference call the same day, at 11:00 AM ET, to review the results.
